Services

Services organized around one market-entry track, not scattered support points

In regulatory programs, the real difficulty is often the coordination between strategy, documentation, testing, clinical evidence, QMS, and representative services. The service model is built around that reality.

Global regulatory strategy and route design

For teams that know the product direction but still need clarity on market sequence, classification, and evidence expectations.

Target-market prioritization and timing logic
Classification assumptions and regulatory framework mapping
Gap review and route planning

EU market access

For MDR / IVDR-related programs that need CE preparation, technical file structuring, and representative coordination.

Technical documentation readiness
Clinical and performance evidence alignment
EU authorized representative coordination

US market access

Support FDA pathway assessment, submission package organization, QSR alignment, and US representative coordination.

510(k) / De Novo route review
Submission package preparation and gap analysis
US representative service coordination

China registration support

Help teams align with NMPA submission logic, local testing requirements, and documentation readiness.

Registration route review
Submission preparation and pre-checks
Local regulatory alignment

Quality systems and technical documentation

Connect ISO 13485, MDSAP, and QSR expectations with the documentation work needed for submissions.

QMS gap review and remediation preparation
Structured technical documentation support
Consistency review before submission

Clinical, testing, and representative coordination

Bring testing requirements, clinical evidence logic, and representative arrangements into one project rhythm.

Performance and testing requirement review
Clinical evaluation and evidence packaging
Representative service and maintenance coordination

Typical Engagements

Common starting points

The product is ready, but the route is not

This usually starts with market prioritization, classification review, and evidence planning.

The route exists, but the package is fragmented

The focus then shifts to document structure, testing and clinical sequencing, and QMS alignment.

The program is already moving and needs continuity

This is where phased collaboration often makes sense, especially when submission and representative work must stay linked.

Start With The Route

Clarify what to prepare first, instead of starting every workstream at once.

Go to contact